![Four big takeaways to wrap up the Paris Air Show [Video]](https://breakingdefense.com/wp-content/uploads/sites/3/2023/06/FCAS-scaled-e1685718848105.jpg?#)
![The sights of Paris Air Show, one last time: Day 4 [Photos]](https://breakingdefense.com/wp-content/uploads/sites/3/2025/06/20250617-helenedelacoste-Paris-Air-Show-037-scaled-e1750357690820.jpg?#)
Syncona blames 'challenging' market for shift in biotech investment strategy
Life sciences investment firm Syncona has blamed “particularly challenging” market conditions for shifting its strategy away from early-stage biotechs and focusing on those companies likely to offer near-term rewards.
Life sciences investment firm Syncona has blamed “particularly challenging” market conditions for shifting its strategy away from early-stage biotechs and focusing on those companies likely to offer near-term rewards.
